| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-9453 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-203 |
| filingDate |
1996-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_907a3cc236af5b190fcd4a502f9b99b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b76d39706061a10ae0a2e45884bba66 |
| publicationDate |
1997-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9704766-A1 |
| titleOfInvention |
Retinoid suppression of ventricular muscle cell hypertrophy |
| abstract |
A method of suppressing ventricular muscle cell hypertrophy induced by an α1-adrenergic agonist or endothelin, by providing an effective amount of a retinoic acid compound. Also provided are methods for identifying compounds which suppress ventricular muscle cell hypertrophy, compounds which inhibit the retinoic acid suppression of ventricular muscle hypertrophy, and therapeutic methods. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019241597-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3806839-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017160261-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7998974-B2 |
| priorityDate |
1995-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |